MRI in Reconstructive Urology
MRI can clarify periurethral and pelvic soft-tissue anatomy when examination, endoscopy, or lumen-based imaging leaves a specific reconstructive question unanswered.[1][2] Order a study around that question and the relevant prior operation. An image-derived length, angle, or signal characteristic is not, by itself, an instruction to perform a particular repair.
At a glance: use MRI selectively for complex posterior urethral disease, female urethral diverticulum, difficult fistulas, or selected pelvic-floor and postoperative problems. Establish the implant and contrast plan before scanning. Interpret findings alongside examination, symptoms, endoscopy, and prior imaging.[1][2][3][4]
1. Overview: What MRI Adds
| Clinical question | Useful MRI contribution | Companion evaluation |
|---|---|---|
| Posterior urethral stenosis or complex PFUI | Periurethral anatomy and associated fistula or other pathology | RUG/VCUG; selected antegrade/retrograde endoscopy |
| Female urethral diverticulum | Extent, configuration, and relationship to urethra and sphincter | Examination and urethroscopy; histology when tissue is removed |
| Selected prolapse or defecatory dysfunction | Dynamic compartment relationships | Symptoms, POP-Q examination, and bowel assessment |
| Difficult postoperative pelvic problem | Deep tissue, collection, tract, or inflammatory change | Operation/device details and targeted endoscopy or ultrasound |
These are indications for problem-solving, not requirements for every patient with these diagnoses.[1][2][5][6]
2. Pelvic Fracture Urethral Injury (PFUI)
When MRI helps
Combined RUG and VCUG remain central for a nearly obliterated or obliterated posterior urethra. The EAU recommends considering MRI urethrography as an ancillary test in posterior stenosis, particularly when associated pathology or complex spatial anatomy matters.[1]
A prospective study of 25 men with complete posterior stenosis found MRI measurements correlated more closely with operative length than conventional urethrography. This small study supports an adjunctive role; it does not establish a universal correction in millimeters to add to RUG measurements.[7]
Request and reporting checklist
Request a dedicated urethral/pelvic protocol and provide the trauma, prior repair, catheter, and endoscopy history. High-resolution T2 images aligned to the relevant anatomy are useful; contrast and additional sequences depend on the question. Document the visible urethral ends, estimated intervening distance and measurement plane, prostatic displacement, and associated abnormalities. If the proximal lumen or bladder neck is inadequately assessed, say so rather than inferring normality.[1][7]
Operative limit: gap length and stump geometry contribute to planning, but the evidence does not support a universal 3-cm gap or 30-degree angle that mandates pubectomy or an abdominal approach. Review imaging with the reconstructive surgeon; bladder-neck appearance on a static scan is not a continence test.[1]
3. Dynamic (Defecation) MRI for Pelvic Organ Prolapse
Select the clinical question
Do not routinely obtain imaging simply to document prolapse already demonstrated on examination. When imaging is needed for complex compartment symptoms, defecatory dysfunction, or unresolved postoperative findings, MR defecography is one option; fluoroscopic and ultrasound examinations answer overlapping questions.[5][6]
Acquisition and reporting
The ESUR/ESGAR consensus recommends static images plus coached squeeze, strain, and evacuation sequences. Record inadequate effort or incomplete evacuation because these can conceal findings. Rectal gel and moderate bladder filling are protocol elements; routine intravenous contrast is unnecessary for standard MR defecography.[8]
The pubococcygeal line runs from the inferior pubic symphysis to the last coccygeal joint. State the reference line, organ landmark, phase, and displacement. Report rectocele depth and anorectal-junction descent separately: the same numerical grading table does not apply to every compartment. Describe levator defects with the method used; a muscle defect is not, alone, a mandate for mesh surgery.[8]
Use the report to reconcile symptoms and examination, then return to the POP clinical pathway. An abnormal image without corresponding bother or functional relevance is not a stand-alone indication for repair.[5]
4. Urethral Diverticulum
Role and limits
MRI is a preferred study for characterizing female urethral diverticulum and planning surgery. Ask for location, dimensions, simple versus multiloculated/circumferential configuration, visible communication with the urethra, and relationship to the sphincter. Fluid-sensitive images can show a small lesion; the ostium is not always demonstrable. Record prior bulking injections because they can mimic pathology.[2][9]
MRI is not infallible. In Chung and colleagues' operated series, 10 of 41 patients who had preoperative MRI had a diagnostic or anatomical discrepancy; cancer within the diverticulum was missed in two. This selected retrospective series is a caution about false reassurance, not an accuracy estimate transferable to every imaging service.[10]
Complexity and surgical planning
Wall thickening, debris, or an enhancing component requires clinical interpretation. Neither an enhancing nodule nor restricted diffusion proves malignancy, and a reassuring MRI cannot exclude it. Persistent clinical concern needs specialist assessment and appropriate tissue diagnosis. Do not assign a continence procedure or a biopsy route from a neck-width cutoff alone.[2][10]
5. Vesicovaginal Fistula (VVF)
Examination, bladder dye testing, and cystoscopy are often the starting point. The EAU supports late-excretory CT and/or MRI when diagnosis is difficult or a ureterovaginal fistula is suspected.[2] For MRI, specify whether the unanswered question concerns a tract, collection, radiation change, or adjacent organ involvement. These may require a different protocol from uncomplicated prolapse imaging.[6]
The report should describe visible tract anatomy and uncertainty. It should not assign a vaginal versus abdominal repair, interposition flap, or ureteral stent on the basis of a fixed millimeter distance alone. Examination, exposure, ureteral involvement, tissue quality, and prior treatment remain part of the VVF assessment.[2]
6. MRI Urethrogram
MRI may add information about periurethral tissues, fistulation, or complex posterior anatomy. Routine anterior strictures usually begin with conventional urethral assessment; MRI is not required simply because urethroplasty is planned.[1]
Describe narrowing and surrounding signal abnormalities without equating MRI signal with histological fibrosis depth. There is no validated universal MRI grade in the cited guidance that independently selects endoscopic treatment, anastomotic repair, onlay, or staged reconstruction. For anterior disease, sonourethrography can be a useful adjunct, with its own limitations.[1]
In women, MRI is particularly useful when another periurethral lesion is suspected. It does not replace clinical, endoscopic, and functional evaluation of obstruction.[2]
7. Peyronie's Disease
MRI is not a routine investigation for Peyronie's disease in current EAU guidance. History, examination, objective erection/curvature assessment, and selected ultrasound or duplex studies guide evaluation. MRI signal should not be used to label an oral treatment effective or to assign grafting from plaque length alone.[11]
Use the Peyronie's treatment atlas and penile Doppler page for the relevant clinical workflow. This MRI page does not provide an erection-induction drug protocol.
8. VI-RADS for Bladder Cancer
VI-RADS is a five-point MRI assessment of the likelihood of muscle invasion, using T2-weighted, diffusion-weighted, and dynamic contrast-enhanced findings in its original multiparametric protocol. It does not assign fixed universal percentage risks to each category or replace endoscopy and histopathology.[12]
For reconstructive practice, its relevance is coordination with the oncology team when a known or suspected bladder lesion affects planning. A low VI-RADS score is not clearance for augmentation, diversion, or treatment of an unexplained bladder abnormality.[12]
9. Upper Tract / MR Urography (MRU)
Choose the technique for the question
| Technique | What it provides | Important limit |
|---|---|---|
| Static-fluid MRU | Heavily T2-weighted depiction of urinary fluid; no injected contrast required | Dilatation does not establish functionally important obstruction |
| Excretory/functional MRU | Contrast excretion, anatomy, and protocol-dependent functional information | Depends on excretion, acquisition, processing, and local expertise |
Hydronephrosis workup depends on symptoms, prior imaging, pregnancy, renal function, and the likely cause. CT urography, MRU, and MAG3 are alternative or complementary investigations; no single study is automatically preferred for every dilated system.[13][14]
MRU avoids ionizing radiation and can be useful for complex congenital anatomy, but examination time, motion, and possible sedation matter. A diuretic protocol must be named and followed as designed; “F+15” and “F−15” are not interchangeable. Interpret drainage with the full examination rather than calling any delayed washout an obstruction.[14] See MAG3 renal scintigraphy for the dedicated functional evaluation.
9.5. Mesh and Sling Complications
Obtain the operative report and device information. MRI can assess deep postoperative pelvic problems; ultrasound can show many slings and accessible mesh segments. Modality selection depends on the suspected complication and local expertise. ACR rates contrast-enhanced MRI as usually appropriate for selected subacute or chronic complications after pelvic-floor repair, a different question from uncomplicated recurrent prolapse.[6]
Neither a normal MRI nor a normal ultrasound excludes every mesh complication. Suspected urinary tract exposure still needs appropriate endoscopic evaluation, and vaginal exposure is assessed clinically. Avoid claiming universal diagnostic sensitivity for a device or using visible mesh position alone as proof that it caused pain.[5]
10. MRI Sequence Quick Reference Table
| Sequence family | Typical contribution | Interpretation boundary |
|---|---|---|
| T2-weighted anatomical imaging | Urethral, periurethral, and pelvic-floor structure | Signal alone is not histology |
| Dynamic cine/defecography | Movement during coached maneuvers | Depends on effort and the phase captured |
| DWI with ADC maps | Additional lesion characterization | Restricted diffusion is not cancer-specific |
| Contrast-enhanced T1 imaging | Selected masses, inflammation, or postoperative complications | Use only when it adds information relevant to the question |
| Heavily T2-weighted MRU | Fluid-filled collecting system anatomy | Does not itself measure drainage adequacy |
This is an orientation table, not a scanner prescription. Protocols are selected with radiology for the clinical indication.[7][8][12][14]
11. Practical Protocol Tips
Implants and MRI safety
For a sacral neuromodulator or another active implanted system, identify the exact generator, leads, and any retained or abandoned components. Apply the current device-specific MR conditions, including field strength, permitted scan region, programming, and other restrictions. “MR Conditional” does not mean safe under every protocol. Unknown or unmet conditions require the radiology service's formal MR risk assessment; a prior uneventful scan is not substitute clearance.[3]
Gadolinium, renal impairment, and pregnancy
The ACR contrast manual distinguishes agents by NSF risk. When gadolinium is necessary in a patient at risk, Group II agents are preferred; renal impairment is not a blanket contraindication to every gadolinium agent. Use the lowest dose that provides a diagnostic examination under the agent's labeling and institutional protocol, rather than an automatic half-dose rule. ACR does not recommend initiating or altering dialysis solely because Group II contrast was administered.[4]
During pregnancy, consider a noncontrast examination or another adequate test first. Gadolinium requires a documented judgment that the expected clinical benefit justifies the uncertain fetal risk; pregnancy is not a reason to casually postpone necessary diagnosis.[4]
Request quality
Include the clinical question, symptom pattern, prior operations, device details, pregnancy status when relevant, and contrast-risk history. Let the MR service tailor bladder filling, coil, field strength, motion reduction, and rectal preparation. A fixed bladder volume or universal antispasmodic prescription is not appropriate across PFUI, diverticulum, defecography, and MRU protocols.[3][4][8][14]
12. References
1. European Association of Urology. Urethral Strictures Guidelines: Diagnostic Evaluation. 2026. Official guideline.
2. European Association of Urology. Non-neurogenic Female LUTS Guidelines: Disease Management (urinary fistula and urethral diverticulum sections). 2026. Official guideline.
3. American College of Radiology. Manual on MR Safety. Current downloadable manual inspected September 11, 2026, including 2026 revisions; see implant identification and risk assessment. Official manual.
4. American College of Radiology. Manual on Contrast Media. 2026. NSF and pregnancy chapters. Official manual.
5. NICE. Urinary Incontinence and Pelvic Organ Prolapse in Women: Management (NG123), recommendations on imaging and mesh complications. Official recommendations. Accessed September 11, 2026.
6. American College of Radiology. ACR Appropriateness Criteria: Pelvic Floor Dysfunction in Females. Revised 2021. Official narrative and scenario-specific ratings.
7. Oh MM, Jin MH, Sung DJ, et al. Magnetic resonance urethrography to assess obliterative posterior urethral stricture: comparison to conventional retrograde urethrography with voiding cystourethrography. J Urol. 2010;183:603–607. doi:10.1016/j.juro.2009.10.016.
8. El Sayed RF, Alt CD, Maccioni F, et al. Magnetic resonance imaging of pelvic floor dysfunction—joint recommendations of the ESUR and ESGAR Pelvic Floor Working Group. Eur Radiol. 2017;27:2067–2085. doi:10.1007/s00330-016-4471-7.
9. Dwarkasing RS, Dinkelaar W, Hop WC, et al. MRI evaluation of urethral diverticula and differential diagnosis in symptomatic women. AJR Am J Roentgenol. 2011;197:676–682. doi:10.2214/AJR.10.6144.
10. Chung DE, Purohit RS, Girshman J, Blaivas JG. Urethral diverticula in women: discrepancies between magnetic resonance imaging and surgical findings. J Urol. 2010;183:2265–2269. doi:10.1016/j.juro.2010.02.016.
11. European Association of Urology. Sexual and Reproductive Health Guidelines: Penile Curvature. 2026. Official guideline.
12. Panebianco V, Narumi Y, Altun E, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS. Eur Urol. 2018;74:294–306. doi:10.1016/j.eururo.2018.04.029.
13. Expert Panel on Urological Imaging. ACR Appropriateness Criteria: Hydronephrosis on Prior Imaging—Unknown Cause. J Am Coll Radiol. 2024;21:S144–S167. doi:10.1016/j.jacr.2024.02.020.
14. Leyendecker JR, Barnes CE, Zagoria RJ. MR urography: techniques and clinical applications. Radiographics. 2008;28:23–46. doi:10.1148/rg.281075077.